Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Effectiveness of reconsolidation therapy with propranolol to treat adjustment disorder (AD) stemming from romantic betrayal: A 2-year follow-up
FY 2018-19
Summary
Considering that romantic betrayal events can result in the development of an adjustment disorder (AD) in the betrayed partner, effective therapies with long-lasting benefits are needed for this population. The aim of the current study is to provide a follow-up assessment of romantically betrayed participants from a previous clinical trial, who received a trauma-focused intervention known as reconsolidation therapy to treat an AD. Research demonstrates that propranolol, a beta-blocker commonly used to treat hypertension, can dampen the emotional intensity of a memory when taken before memory recall. Propranolol does so by effectively disrupting memory reconsolidation, a process by which memories are reinforced. The previous study found that compared to participants on the wait-list, 4-6 sessions of reconsolidation therapy reduced stressor-related symptoms, and symptoms of depression and anxiety. Still, little is known of the long-term effectiveness of reconsolidation therapy. The current study will therefore examine whether reconsolidation therapy shows long-term benefits for romantically betrayed individuals with an AD. Compared to participants who did not complete the treatment, those who completed the treatment are expected to show a continued reduction in stressor-related, depression, and anxiety symptoms, 2-years following treatment. These findings may have important implications for understanding romantic betrayal as a stressful event leading to the development of AD and may further our understanding of effective treatments for this population.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
406514
Name
Pigeon Sereena
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effectiveness of reconsolidation therapy with propranolol to treat adjustment disorder (AD) stemming from romantic betrayal: A 2-year follow-up
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adjustment Disorder; Follow-Up; Reconsolidation Therapy; Romantic Betrayal
Abstract
Considering that romantic betrayal events can result in the development of an adjustment disorder (AD) in the betrayed partner, effective therapies with long-lasting benefits are needed for this population. The aim of the current study is to provide a follow-up assessment of romantically betrayed participants from a previous clinical trial, who received a trauma-focused intervention known as reconsolidation therapy to treat an AD. Research demonstrates that propranolol, a beta-blocker commonly used to treat hypertension, can dampen the emotional intensity of a memory when taken before memory recall. Propranolol does so by effectively disrupting memory reconsolidation, a process by which memories are reinforced. The previous study found that compared to participants on the wait-list, 4-6 sessions of reconsolidation therapy reduced stressor-related symptoms, and symptoms of depression and anxiety. Still, little is known of the long-term effectiveness of reconsolidation therapy. The current study will therefore examine whether reconsolidation therapy shows long-term benefits for romantically betrayed individuals with an AD. Compared to participants who did not complete the treatment, those who completed the treatment are expected to show a continued reduction in stressor-related, depression, and anxiety symptoms, 2-years following treatment. These findings may have important implications for understanding romantic betrayal as a stressful event leading to the development of AD and may further our understanding of effective treatments for this population.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pigeon, Sereena
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~